Chlorhexidine: a Multi-Functional Antimicrobial Drug a Peer-Reviewed Publication Written by Gary J
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Probiotic Alternative to Chlorhexidine in Periodontal Therapy: Evaluation of Clinical and Microbiological Parameters
microorganisms Article Probiotic Alternative to Chlorhexidine in Periodontal Therapy: Evaluation of Clinical and Microbiological Parameters Andrea Butera , Simone Gallo * , Carolina Maiorani, Domenico Molino, Alessandro Chiesa, Camilla Preda, Francesca Esposito and Andrea Scribante * Section of Dentistry–Department of Clinical, Surgical, Diagnostic and Paediatric Sciences, University of Pavia, 27100 Pavia, Italy; [email protected] (A.B.); [email protected] (C.M.); [email protected] (D.M.); [email protected] (A.C.); [email protected] (C.P.); [email protected] (F.E.) * Correspondence: [email protected] (S.G.); [email protected] (A.S.) Abstract: Periodontitis consists of a progressive destruction of tooth-supporting tissues. Considering that probiotics are being proposed as a support to the gold standard treatment Scaling-and-Root- Planing (SRP), this study aims to assess two new formulations (toothpaste and chewing-gum). 60 patients were randomly assigned to three domiciliary hygiene treatments: Group 1 (SRP + chlorhexidine-based toothpaste) (control), Group 2 (SRP + probiotics-based toothpaste) and Group 3 (SRP + probiotics-based toothpaste + probiotics-based chewing-gum). At baseline (T0) and after 3 and 6 months (T1–T2), periodontal clinical parameters were recorded, along with microbiological ones by means of a commercial kit. As to the former, no significant differences were shown at T1 or T2, neither in controls for any index, nor in the experimental -
Phenol Health and Safety Guide
C - z_ IPCS INTERNATIONAL._ PROGRAMME ON CHEMICAL SAFETY OD 341 Health and Safety Guide No. 88 .P5 94 Ph c.2 PHENOL HEALTH AND SAFETY GUIDE ' UNITED NATIONS INTERNATIONAL ENVffiONMENTPROG~E LABOUR ORGANISATION WORLD HEALTH ORGANIZATION WORLD HEALTH ORGANIZATION, GENEVA 1994 1 I) 1\ ' ~Ii>cs Other HEALTH AND SAFETY GUIDES available: (continued on inside back cover) Acrolein (No . 67, 1992) Endrin (No. 60, 1991) Acrylamide (No. 45 , 1991) Epichlorohydrin (No. 8, 1987) Acrylonitrile (No. I, 1986) Ethylene oxide (No. 16, 1988) Aldicarb (No. 64, 1991) Fenitrothion (No. 65, 1991) Aldrin and dieldrin (No. 21 , 1988) Fenvalerate (No. 34, 1989) Allethrins (No. 24, 1989) Folpet (No. 72, 1992) Amitrole (No. 85 , 1994) Formaldehyde (No. 57, 1991) Ammonia (No. 37, 1990) Heptachlor (No. 14, 1988) Arsenic compounds, inorganic, other than Hexachlorobutadiene (No. 84, 1993) arsine (No. 70, 1992) Hexachlorocyclohexanes, alpha- and Atrazine (No. 47, 1990) beta- (No. 53, 1991) Barium (No. 46 , 1991) Hexachlorocyclopentadiene (No. 63 , 1991) Benomyl (No. 81, 1993) n-Hexane (No. 59, 1991) Bentazone (No. 48, 1990) Hydrazine (No. 56, 1991) Beryllium (No. 44, 1990) Isobenzan (No. 61 , 1991) !-Butanol (No. 3, 1987) Isobutanol (No. 9, 1987) 2-Butanol (No. 4, 1987) Kelevan (No. 2, 1987) ten-Butanol (No. 7, 1987) Lindane (No. 54 , 1991) Camphechlor (No. 40, 1990) Magnetic fields (No. 27, 1990) Captafol (No. 49, 1990) Methamidophos (No. 79, 1993) Captan (No. 50, 1990) Methyl bromide (Bromomethane) (No. 86, 1994) Carbaryl (No. 78, 1993) Methyl isobutyl ketone (No. 58, 1991) Carbendazim (No. 82, 1993) Methyl parathion (No. 75, 1992) Chlordane (No. 13 , 1988) Methylene chloride (No. -
Chemical Matricectomy with Phenol Versus Aesthetic Reconstruction. a Single Blinded Randomized Clinical Trial
Journal of Clinical Medicine Article The Treatment of Ingrown Nail: Chemical Matricectomy With Phenol Versus Aesthetic Reconstruction. A Single Blinded Randomized Clinical Trial Juan Manuel Muriel-Sánchez 1, Ricardo Becerro-de-Bengoa-Vallejo 2 , Pedro Montaño-Jiménez 1 and Manuel Coheña-Jiménez 1,* 1 Facultad de Enfermería, Fisioterapia y Podología, Universidad de Sevilla, 41009 Sevilla, Spain; [email protected] (J.M.M.-S.); [email protected] (P.M.-J.) 2 Facultad de Enfermería, Fisioterapia y Podología, Universidad Complutense de Madrid, 28040 Madrid, Spain; [email protected] * Correspondence: [email protected] Received: 29 January 2020; Accepted: 18 March 2020; Published: 20 March 2020 Abstract: Background: In onychocryptosis surgery, incisional and non-incisional matricectomy is indicated according to the stage. The chemical matricectomy with 88% phenol solution is the gold standard and a wedge resection is indicated for more advanced stages. The aesthetic reconstruction has the advantages of the incisional procedure without eponychium incisions and an effectiveness similar to the chemical matricectomy with phenol. Objective: To compare the recurrence and the healing time between the chemical matricectomy with phenol and the aesthetic reconstruction. Methods: A comparative, prospective, parallel, randomized, and one-blinded clinical trial was registered with the European Clinical Trials Database (EudraCT) with identification number 2019-001294-80. Thrity-four patients (56 feet) with 112 onychocryptosis were randomized in two groups. Thirty-six were treated with chemical matricectomy with phenol and 76 with aesthetic reconstruction. Each patient was blind to the surgical procedure assigned by the investigator. The primary outcome measurements were healing time and recurrence. The secondary outcome measurements were post-surgical bleeding, pain, inflammation, and infection rate. -
Periodontal Health, Gingival Diseases and Conditions 99 Section 1 Periodontal Health
CHAPTER Periodontal Health, Gingival Diseases 6 and Conditions Section 1 Periodontal Health 99 Section 2 Dental Plaque-Induced Gingival Conditions 101 Classification of Plaque-Induced Gingivitis and Modifying Factors Plaque-Induced Gingivitis Modifying Factors of Plaque-Induced Gingivitis Drug-Influenced Gingival Enlargements Section 3 Non–Plaque-Induced Gingival Diseases 111 Description of Selected Disease Disorders Description of Selected Inflammatory and Immune Conditions and Lesions Section 4 Focus on Patients 117 Clinical Patient Care Ethical Dilemma Clinical Application. Examination of the gingiva is part of every patient visit. In this context, a thorough clinical and radiographic assessment of the patient’s gingival tissues provides the dental practitioner with invaluable diagnostic information that is critical to determining the health status of the gingiva. The dental hygienist is often the first member of the dental team to be able to detect the early signs of periodontal disease. In 2017, the American Academy of Periodontology (AAP) and the European Federation of Periodontology (EFP) developed a new worldwide classification scheme for periodontal and peri-implant diseases and conditions. Included in the new classification scheme is the category called “periodontal health, gingival diseases/conditions.” Therefore, this chapter will first review the parameters that define periodontal health. Appreciating what constitutes as periodontal health serves as the basis for the dental provider to have a stronger understanding of the different categories of gingival diseases and conditions that are commonly encountered in clinical practice. Learning Objectives • Define periodontal health and be able to describe the clinical features that are consistent with signs of periodontal health. • List the two major subdivisions of gingival disease as established by the American Academy of Periodontology and the European Federation of Periodontology. -
Partial Nail Avulsion and Chemical Matricectomy: Ingrown Toenails
Partial nail avulsion and chemical matricectomy: Ingrown toenails Intervention Removal (avulsion) of an ingrowing section of toenail and application of a caustic chemical to destroy the nail matrix (matricectomy). Indication Partial nail avulsion and chemical matricectomy relieve symptoms and prevent regrowth of the nail edge or recurrence of the ingrowing toenail. Possible causes of ingrowing toenails include improper Ingrowing toenails are a common problem and occur when the edge of the nail grows trimming of the nail, tearing nail into flesh at the side of the nail, causing a painful injury. The punctured skin can become off, overly curved nail, certain inflamed and infected. Ingrown toenails can be classified into three stages (see Figure 1): activities (eg running) and • mild (or Stage I) wearing constricting footwear. – oedema, erythema and pain • moderate (or Stage II) – inflammation and inflection with or without purulent discharge, in addition to the symptoms of Stage I • severe (or Stage III) – chronic inflammation, epithelialised hypertrophic granulation tissue. Figure 1. Three stages of ingrown toenails Source: Eekhof JA, Van Wijk B, Knuistingh Neven A, van der Wouden JC. Interventions for ingrowing toenails. The Cochrane Database of Systematic Reviews 2012;4:CD001541. Surgical interventions are commonly performed for patients in Stages II and III, and are more effective than non-surgical interventions in preventing the recurrence of an ingrowing toenail. The addition of chemical cauterisation (most commonly with phenol) at Stages II and III, may be more effective in preventing recurrence and regrowth of the ingrowing toenail than surgery alone. Contraindications Diminished vascular supply to the digit is a relative contraindication to nail surgery. -
Hatchery Disinfection Policy and Procedures
MAINE DEPARTMENT OF INLAND FISHERIES & WILDLIFE Chapter 11 Disinfection Policy & Procedures Editors: David C. Rayner, Fish Culture Supervisor, Governor Hill State Fish Hatchery, Augusta, Maine (19XX- Present) & G. Russell Danner MS, DVM, Fish Pathologist, Fish Health Laboratory, Augusta, Maine (1998 – Present) Date: September 24, 1999. “Or if a person touches anything ceremonially unclean-whether the carcasses of unclean wild animals or of unclean livestock or of unclean creatures that move along the ground-even though he is unaware of it, he has become unclean and is guilty” Lev. 5:2 Several factors should be included in an evaluation of a disinfectant. A prerequisite for a disinfectant is its effectiveness against the expected spectrum of pathogens (Table 11- 1, 11-2, and 11-3). A general guideline for effective killing of pathogens by a disinfectant is a 5-log killing of bacteria and a 4-log killing of viruses. In addition to the activity of the disinfectant, its compatibility with devices should be reviewed in detail; this should include a review of data on devices that have been immersed for longer than recommended times. Instruments can be forgotten after immersion, and this mistake should not necessarily result in irreparable damage to the device. Other issues are toxicity, odor, compatibility with other compounds, and residual activity. Various and numerous organisms can cause diseases in fish. Viruses, bacteria, fungi, protozoan and many invertebrate animals are included in this list. No single disinfectant destroys them all. It is up to the applicant to decide what is the pathogen of most concern, and how it is to be reduced or eliminated. -
Phenol Red Solution, 1.0% Alcoholic MSDS # 523.00
Material Safety Data Sheet Page 1 of 2 Phenol Red Solution, 1.0% Alcoholic MSDS # 523.00 Section 1: Product and Company Identification Phenol Red Solution, 1.0% Alcoholic Synonyms/General Names: N/A Product Use: For educational use only Manufacturer: Columbus Chemical Industries, Inc., Columbus, WI 53925. 24 Hour Emergency Information Telephone Numbers CHEMTREC (USA): 800-424-9300 CANUTEC (Canada): 613-424-6666 ScholAR Chemistry; 5100 W. Henrietta Rd, Rochester, NY 14586; (866) 260-0501; www.Scholarchemistry.com Section 2: Hazards Identification Red to orange color liquid, mild odor. HMIS (0 to 4) Health 1 WARNING! Alcohol based solution, flammable liquid and moderately toxic by ingestion. Fire Hazard 3 Flammable liquid, keep away from all ignition sources. Reactivity 0 Target organs: Central nervous system, liver, kidneys. This material is considered hazardous by the OSHA Hazard Communication Standard (29 CFR 1910.1200). Section 3: Composition / Information on Ingredients Phenol Red, sodium salt (3447-61-1), 1%. Isopropyl Alcohol (67-63-0), 49.5%. Water (7732-18-5), 49.5%. Section 4: First Aid Measures Always seek professional medical attention after first aid measures are provided. Eyes: Immediately flush eyes with excess water for 15 minutes, lifting lower and upper eyelids occasionally. Skin: Immediately flush skin with excess water for 15 minutes while removing contaminated clothing. Ingestion: Call Poison Control immediately. Aspiration hazard. Rinse mouth with cold water. Give victim 1-2 tbsp of activated charcoal mixed with 8 oz water. Inhalation: Remove to fresh air. If not breathing, give artificial respiration. Section 5: Fire Fighting Measures Class IB Flammable Liquid. -
(Ie Bacteria).The Term Is Used for Both Treatment of Cancer and Treatment of Infection
BASIC PRINCIPLES OF ANTIMICROBIAL THERAPY • Chemotherapy = the use of chemicals against invading organisms (ie bacteria).The term is used for both treatment of cancer and treatment of infection. • Antibiotic = a chemical that is produced by one microorganism and has the ability to harm other microbes. • Selective toxicity = the ability of a drug to injure a target cell or organism without injuring other cells or organisms that are in intimate contact . CLASSIFICATION OF ANTIMICROBIAL DRUGS BY SUSCEPTIBLE ORGANISMS • 1) Antibacterial drugs (narrow and broad spectrum).Examples: Penicillin G, erythromycin,cephalosporins,sulfonamides • • 2) Antiviral drugs (examples:acyclovir,amantadine) • 3) Antifungal drugs • (examples : amphotericin,ketoconazole) 1 CLASSIFICATION BY MECHANISM OF ACTION • 1) Drugs that inhibit bacterial wall synthesis or activate enzymes that disrupt the cell wall. • 2) Drugs that increase cell membrane permeability (causing leakage of intracellular material) • 3) Drugs that cause lethal inhibition of bacterial protein synthesis. • 4) Drugs that cause nonlethal inhibition of protein synthesis (bacteriostatics). • 5) Drugs that inhibit bacterial synthesis of nucleic acids • 6) Antimetabolites (disruption of specific biochemichal reactions-->decrease in the synthesis of essential cell constituents). • 7) Inhibitors of viral enzymes. • Acquired resistance to Antimicrobial drugs. • Mechanisms: • 1) Microbes may elaborate drug-metabolizing enzymes (ie penicillinase). 2 • 2) Microbes may cease active uptake of certain drugs • 3) Microbial drug receptors may undergo change resulting in decreased antibiotic binding and action. • 4) Microbes may synthesize compounds that antagonize drug actions. • How is resistance acquired? • A) Spontaneous mutation • B) Conjugation • Use of antibiotics PROMOTES the emergence of drug-resistant microbes. • Suprainfection (or supeinfection) : a new infection that appears through the course of treatment for a primary infection. -
Antimicrobial Agents David S
University of Montana ScholarWorks at University of Montana Syllabi Course Syllabi Spring 1-2003 PHAR 328.01: Antimicrobial Agents David S. Freeman University of Montana - Missoula Let us know how access to this document benefits ouy . Follow this and additional works at: https://scholarworks.umt.edu/syllabi Recommended Citation Freeman, David S., "PHAR 328.01: Antimicrobial Agents" (2003). Syllabi. 4290. https://scholarworks.umt.edu/syllabi/4290 This Syllabus is brought to you for free and open access by the Course Syllabi at ScholarWorks at University of Montana. It has been accepted for inclusion in Syllabi by an authorized administrator of ScholarWorks at University of Montana. For more information, please contact [email protected]. PHARMACY 328 (ANTIMICROBIAL AGENTS) SPRING SEMESTER, 2003 INSTRUCTOR: David Freeman, Office - SB 308 Office Phone: 243-4772 Home Phone: 728-6551 E-mail: [email protected] EXAMS AND GRADING: First Exam: Tuesday, MARCH 4 50 points Second Exam: Thursday, APRIL 3 70 points Third Exam: Thursday, MAY 1 80 points Final Exam: 100 points 10 Point Quizzes: Best 5 or 6 out of 6 scores . 50 or 60 points Total Points: 350, or 360 90-100% = A 80-89 % = B 70-79 % = C 65-69 % = D * All EXAMS are comprehensive * All exams and quizzes must be taken at scheduled times * Instructor must be informed BEFORE missing a scheduled exam period and MUST be based on GOOD REASONS * Missed exam periods must be made up within 2 days * No make up quizzes STUDENT PERFORMANCE OBJECTIVES: 1) Know the normal relevant biochemical -
Prevotella Intermedia
The principles of identification of oral anaerobic pathogens Dr. Edit Urbán © by author Department of Clinical Microbiology, Faculty of Medicine ESCMID Online University of Lecture Szeged, Hungary Library Oral Microbiological Ecology Portrait of Antonie van Leeuwenhoek (1632–1723) by Jan Verkolje Leeuwenhook in 1683-realized, that the film accumulated on the surface of the teeth contained diverse structural elements: bacteria Several hundred of different© bacteria,by author fungi and protozoans can live in the oral cavity When these organisms adhere to some surface they form an organizedESCMID mass called Online dental plaque Lecture or biofilm Library © by author ESCMID Online Lecture Library Gram-negative anaerobes Non-motile rods: Motile rods: Bacteriodaceae Selenomonas Prevotella Wolinella/Campylobacter Porphyromonas Treponema Bacteroides Mitsuokella Cocci: Veillonella Fusobacterium Leptotrichia © byCapnophyles: author Haemophilus A. actinomycetemcomitans ESCMID Online C. hominis, Lecture Eikenella Library Capnocytophaga Gram-positive anaerobes Rods: Cocci: Actinomyces Stomatococcus Propionibacterium Gemella Lactobacillus Peptostreptococcus Bifidobacterium Eubacterium Clostridium © by author Facultative: Streptococcus Rothia dentocariosa Micrococcus ESCMIDCorynebacterium Online LectureStaphylococcus Library © by author ESCMID Online Lecture Library Microbiology of periodontal disease The periodontium consist of gingiva, periodontial ligament, root cementerum and alveolar bone Bacteria cause virtually all forms of inflammatory -
Components of a Vaccine
Components of a vaccine Vaccines include a variety of ingredients including antigens, stabilizers, adjuvants, antibiotics, and preservatives. They may also contain residual by-products from the production process. Knowing precisely what is in each vaccine can be helpful when investigating adverse events following immunization (AEFIs) and for choosing alternative products for those who have allergies or have had an adverse event known or suspected to be related to a vaccine component. Antigens Antigens are the components derived from the structure of disease-causing organisms, which are recognized as 'foreign' by the immune system and trigger a protective immune response to the vaccine. You have already learned about antigens. Click here if you want to review the chapter on antigens. Stabilizers Stabilizers are used to help the vaccine maintain its effectiveness during storage. Vaccine stability is essential, particularly where the cold chain is unreliable. Instability can cause loss of antigenicity and decreased infectivity of LAV. Factors affecting stability are temperature and acidity or alkalinity of the vaccine (pH). Bacterial vaccines can become unstable due to hydrolysis and aggregation of protein and carbohydrate molecules. Stabilizing agents include MgCl2 (for OPV), MgSO4 (for measles), lactose- sorbitol and sorbitol-gelatine. Adjuvants Adjuvants are added to vaccines to stimulate the production of antibodies against the vaccine to make it more effective. Aluminium salts example Adjuvants have been used for decades to improve the immune response to vaccine antigens, most often in inactivated (killed) vaccines. In conventional vaccines, adding adjuvants into vaccine formulations is aimed at enhancing, accelerating and prolonging the specific immune response to vaccine antigens. -
Prophylactic Use of Antibiotics in Dentistry
VIDENSKAB OG KLINIK | Oversigtsartikel ABSTRACT Prophylactic use Antibiotic prophylaxis can prevent the develop- of antibiotics in ment of either systemic or local infectious dentistry complications Riina Richardson, lecturer in oral medicine and Senior Clinical Re- The indications for the use of antimicrobials in search Fellow and Honorary Consultant in Infectious Diseases, dentistry are (i) treatment of acute infection and Adjunct Professor, DDS, PhD, FRCPath, Institute of Dentistry, Univer- sity of Helsinki, Finland, Department of Oral and Maxillofacial Disea- (ii) prophylaxis against infection (single-dose ses, Helsinki University Hospital, Finland, and Manchester Academic prophylaxis and perioperative prophylaxis). An- Health Science Centre, School of Translational Medicine, University of Manchester and University Hospital of South Manchester, United tibiotic prophylaxis refers to the administration Kingdom of antimicrobials in situations where there is no Elina Ketovainio, DDS, Institute of Dentistry, University of Helsinki, actual infection, but where the risk of infection Finland and Department of Oral and Maxillofacial Diseases, Helsinki is substantial, for example, in the case of inva- University Hospital, Finland sive procedures at contaminated sites. The Asko Järvinen, head of Department, adjunct Professor, MD, PhD, spe- aim of antibiotic prophylaxis is to prevent the cialist in internal medicine, infectious diseases and clinical pharma- development of either systemic or local infec- cology, Department of medicine, Clinic of Infectious Diseases, Hel- sinki University Hospital, Aurora Hospital, Helsinki, Finland tion complications. Severe underlying diseases including immunosuppressive illnesses and their treatment have been shown to predispose the patient to systemic odontogenic infections. he indications for antimicrobials in dentistry are treat- Manipulation of infected oral tissues, such as ment of acute infection and infection prophylaxis (sin- measurement of periodontal pockets, calculus T gle-dose prophylaxis and perioperative prophylaxis).